Perella Weinberg Partners Capital Management’s Pacira BioSciences PCRX Stock Holding History

Perella Weinberg Partners Capital Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-33,412	Closed	-$3.24M	–	124
2014 Q3	$3.24M	Sell	33,412 -16,842	-34%	-$1.64M	0.36%	85
2014 Q2	$4.62M	Sell	50,254 -37,412	-43%	-$2.85M	0.35%	72
2014 Q1	$6.14M	Buy	87,666 +4,270	+5%	+$290K	0.81%	37
2013 Q4	$4.79M	Buy	83,396 +3,206	+4%	+$169K	0.59%	52
2013 Q3	$3.86M	Sell	80,190 -353,012	-81%	-$12.9M	0.41%	67
2013 Q2	$12.6M	Buy	+433,202	New	+$12.5M	0.85%	34

Other funds holding PCRX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCM

Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perella Weinberg Partners Capital Management's PCRX Position: Q4 2014 in Review

Perella Weinberg Partners Capital Management sold out of Pacira BioSciences (PCRX) in Q4 2014, closing a stake of 33,412 shares — an estimated $3.24M sold.

Perella Weinberg Partners Capital Management first reported a position in PCRX in Q2 2013 and held it in 6 quarters. The position peaked at $12.6M in Q2 2013. 200 funds tracked by Wall St. Rank hold PCRX as of Q4 2014.

Perella Weinberg Partners Capital Management reported no remaining Pacira BioSciences position as of Q4 2014 after selling out during the quarter.
Perella Weinberg Partners Capital Management sold 33,412 Pacira BioSciences shares in Q4 2014, an estimated $3.24M.
Perella Weinberg Partners Capital Management first reported a position in Pacira BioSciences in Q2 2013 and held it in 6 quarters.
Perella Weinberg Partners Capital Management's Pacira BioSciences position peaked at $12.6M in Q2 2013.
200 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2014.

Based on Perella Weinberg Partners Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.